Source Name:Journal of Clinical Oncology
Source URL: http://jco.ascopubs.org/content/early/2014/07/28/JCO.2014.55.9070?cmpid=jco_pap_…
Author(s): Andrew R. Davies, James A. Gossage, Janine Zylstra, Fredrik Mattsson, Jesper Lagergren, Nick Maisey, Elizabeth C. Smyth, David Cunningham, William H. Allum and Robert C. Mason
Using data from 2 centers in London, outcomes after induction therapy and resection for esophageal cancer were analyzed according to the pathological response to induction therapy. Downstaging was the strongest predictor of survival (HR 0.43). Downstaging was also associated with a lower rate of local recurrence (6% vs 13%) and systemic recurrence (19% vs 29%). Pathologic stage after induction therapy was a stronger predictor of survival that was pretreatment clinical stage.
Hi, this is a comment.
To delete a comment, just log in and view the post's comments. There you will have the option to edit or delete them.